News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
GE Healthcare Life Sciences has agreed to build a modular biopharmaceutical factory in China for JHL Biotech, which could be a model for ways to grow local manufacturing in emerging markets.
Novo Nordisk says Adimab’s yeast-based monoclonal antibody (mAb) technology will significantly upgrade its discovery programme.
MIT engineers have developed a new nanoparticle that can protect a vaccine long enough to generate a strong immune response on mucosal surfaces far from the vaccination site.
ATMI says its new line of vials for use in the downstream process is pyrogen-free and sterile upon delivery.